Open AccessProfessionals’ Treatment Preferences in the Prodromal Phase of Parkinson’s Disease: A Discrete Choice Experiment
Author(s) -
Lieneke van den Heuvel,
Wibe Hoefsloot,
Bart Post,
Marjan J. Meinders,
Bastiaan R. Bloem,
Anne M. Stiggelbout,
Janine Astrid van Til
Publication year - 2022
Publication title -
journal of parkinson's disease/journal of parkinson's disease (online)
Language(s) - English
Resource type - Journals
eISSN - 1877-718X
pISSN - 1877-7171
DOI - 10.3233/jpd-223208
Subject(s) - disease , neurology , health professionals , parkinson's disease , medicine , prodromal stage , expectancy theory , life expectancy , psychology , clinical psychology , psychiatry , health care , dementia , population , social psychology , environmental health , economics , economic growth
In Parkinson's disease (PD), several disease-modifying treatments are being tested in (pre-)clinical trials. To successfully implement such treatments, it is important to have insight into factors influencing the professionals' decision to start disease-modifying treatments in persons who are in the prodromal stage of PD.